MDL Orders

OrderDateSubject
OrderJune 4, 2024Order Granting Motion of the Directors of the Tribal Abatement Fund Trust IV and the Tribal Abatement Fund Trust VI for an Order Waiving Annual Report Audit Requirements
OrderApril 10, 2024Order to Establish Taft X Professionals Fee Fund and Endo Public Opioid Political Subdivision Costs and Fees Fund
OrderMarch 28, 2024Fee Panel Order No. 33 Regarding Eligibility of Rhode Island Subdivisions for Teva and Allergan Contingency Fee Funds
OrderFebruary 7, 2024Fee Panel Order No. 30 Regarding Extending Application Deadline for Settling Pharmacies Contingency Fee Award
OrderJanuary 23, 2024Fee Panel Order No. 29 Regarding Application Deadline for Settling Pharmacies Contingency Fee Awards
OrderJanuary 3, 2024Order Granting PEC and TLC Motion to Confirm Fee Panel Determination of Common Benefit Awards for Tribal Work Concurrently and in Conjunction with Other Common Benefit Work
OrderDecember 18, 2023Fee Panel Order No. 28 Regarding Applications Received for Awards from the Teva/Allergan Contingency Fee Fund
OrderNovember 30, 2023Order to Establish Qualified Settlement Fund and Appoint Settlement Referee for Sandoz Settlement Agreement
OrderOctober 2, 2023Order Designating Special Master Pursuant to Global Tribal Opioid Settlement Agreements
OrderAugust 28, 2023Order to Show Cause Regarding the Motion to Dismiss at Docket No. 467
OrderJuly 24, 2023Fee Panel Order No. 25 Regarding Back-Stop Funds in the State of Michigan
OrderJuly 6, 2023Order Regarding 7.5% Common Benefit Assessments
OrderJune 29, 2023Fee Panel Order No. 23 Regarding Communication with Counsel and Third Parties
OrderJune 27, 2023Order to Establish Qualified Settlement Funds, Appoint Panel of Common Benefit and Contingency Fee Fund Arbiters, Approve Fee Fund Allocation and Distribution Process, and Approve Common Benefit Cost Payment and Assessment
OrderJune 27, 2023Order Regarding Recent Settlement Agreements
OrderJune 26, 2023Order to Establish Qualified Settlement Fund, Appoint Panel of Common Benefit and Contingency Fee Fund Arbiters, Approve Fee Fund Allocation and Distribution Process, and Approve Common
OrderFebruary 24, 2023Benefit Cost Payment and Assessment
NoticeFebruary 24, 2023Notice to All Counsel Representing Commonwealth of Pennsylvania Parties of Their Eligibility to Apply for Reimbursement of Contingency Fees from the Pennsylvania Opioid Fee Fund Relating to the Settlements with the Distributor and J&J Defendants
OrderFebruary 22, 2023Order to Establish Additional Qualified Settlement Funds
OrderFebruary 21, 2023Order to Establish Qualified Settlement Funds and Appoint QSF Administrator
OrderJanuary 25, 2023Order Regarding Master Stipulation of Dismissal of Claims Against Settling Defendants
OrderJanuary 4, 2023Order Granting Settling Defendants’ Motion to Stay Further Briefing on Settling Defendants’ Motion to Dismiss Claims Filed by Non-Participating Georgia Subdivisions as Barred by Statute
OrderDecember 21, 2022Non-Document Order
OrderDecember 21, 2022Fee Panel Order No. 18 Regarding Rhode Island Attorney Fee Fund Payments to Distributors
OrderDecember 14, 2022Appeal Order
OrderDecember 14, 2022Appeal Order
OrderDecember 14, 2022Appeal Order
OrderDecember 13, 2022Fee Panel Order No. 17 Regarding Back-Stop Funds in the State of Georgia
OrderDecember 13, 2022Fee Panel Order No. 16 Regarding Back-Stop Funds in the State of Kentucky
OrderDecember 8, 2022Fee Panel Order No. 15 Regarding Back-Stop Funds in the State of New Mexico
OrderDecember 5, 2022Non-document Order granting Agreed Motion Modifying Track 8 Deadlines as to CVS, Kroger, Walgreens, and Walmart
OrderDecember 2, 2022Stipulated Order Entering Stay and Modifying Track 11 Deadlines
OrderNovember 28, 2022Non-Document Order
OrderNovember 20, 2022Fee Panel Order No. 12 Regarding Sharing of Information with State Attorneys General
OrderAugust 17, 2022Injunction Order
OrderAugust 17, 2022Abatement Order
OrderAugust 12, 2022Plaintiffs’ Second Notice of Supplemental Authority
OrderAugust 12, 2022Findings of Fact and Conclusions of Law re Walgreens
OrderAugust 3, 2022Findings of Fact and Conclusions of Law on Order Denying Pharmacy Defendants’ Motions to Dismiss Complaints and Amended Complaints
OrderJune 17, 2022Order Appointing the Fee Panel to Allocate and Disburse Attorney Fees Provided for in State Back-Stop Agreements
OrderJune 17, 2022Fee Panel Order No. 8 Regarding Fee Application Questions
OrderJune 13, 2022Fee Panel Order No. 7
6/8 Order 5/9 OrderJune 8, 2022 (and May 9, 2022 predecessor)Ongoing Common Benefit Order; Order Clarifying Ongoing Common Benefit Order
OrderMay 27, 2022Fee Panel Order No. 4
OrderMay 13, 2022Fee Panel Order No. 3: Contingency Fee Awards
5/9 Order 6/8 OrderMay 9, 2022 (and June 8, 2022 successor order)Ongoing Common Benefit Order; Order Clarifying Ongoing Common Benefit Order
OrderApril 19, 2022Fee Panel Order No. 1
OrderApril 1, 2022Order Establishing Application Protocols for Reimbursement of Common Benefit Attorneys’ Fees Under the Janssen and Distributors Settlement Agreements
OrderMarch 23, 2022Non-Document Order
OrderMarch 8, 2022Order Approving Attorney Fee Fund Start-Up Matters
OrderFebruary 25, 2022Order Clarifying the “CMO Effective Date” for Cases of Non-Participating Subdivisions
OrderFebruary 25, 2022Order Appointing Fee Committee
OrderDecember 16, 2021Decision and Order on Appeal
OrderOctober 18, 2021Order Regarding McKinsey’s Motion to Vacate
OrderOctober 15, 2021Order Regarding Fee Panel, Fund Administrator, and Assistants
OrderAugust 12, 2021Order to Establish Qualified Settlement Fund, Appoint Panel Of Common Benefit and Contingency Fee Fund Arbiters, Approve Fee Fund Allocation And Distribution Process, and Approve Common Benefit Cost Payment and Assessment
OrderAugust 6, 2021Contingency Cap Order